COLOTEST
Live / Allowed — Notice of allowance issued (as of 02 Dec 2025)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 26 Jul 2023 filing date already counts against anyone who files later.
Record
- Serial number
- 98102973
- Mark type
- Stylized text
- Filed
- 26 Jul 2023
- Published for opposition
- 07 Oct 2025
- Attorney of record
- LINDSEY N. ROTHROCK
Goods and services
- Class 005 — Pharmaceuticals: Fecal occult blood test kits comprised of chemically treated papers, test cassettes, and collection tubes for use in the detection of fecal occult blood; Chemically treated papers for use in the detection of fecal occult blood; all of the foregoing excluding diagnostic preparations for medical or veterinary purposes
- Class 010 — Medical apparatus: Medical testing apparatus for use in the detection of fecal occult blood; Medical test kits for detecting fecal occult blood comprised of a blood testing apparatus; Medical apparatus for fecal analysis; all of the foregoing excluding medical diagnostic apparatus
Owner
- Reese Pharmaceutical Company, Cleveland, OH, US
- Reese Pharmaceutical Company, Cleveland, OH, US
Prosecution history
- 02 Dec 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 07 Oct 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 07 Oct 2025 — PUBLISHED FOR OPPOSITION
- 01 Oct 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 07 Sept 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 16 Jul 2025 — EXPARTE APPEAL TERMINATED
- 16 Jul 2025 — EXPARTE APPEAL DISMISSED AS MOOT
- 20 Feb 2025 — EX PARTE APPEAL-INSTITUTED
- 20 Feb 2025 — EXPARTE APPEAL RECEIVED AT TTAB
- 18 Nov 2024 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
- 18 Nov 2024 — APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
- 21 Aug 2024 — NOTIFICATION OF FINAL REFUSAL EMAILED
- 21 Aug 2024 — FINAL REFUSAL E-MAILED
- 21 Aug 2024 — FINAL REFUSAL WRITTEN
- 28 Jun 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED